Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
---|
03/14/2007 | CN1927843A Compound of 2-substituted alkylacrylate and application thereof |
03/14/2007 | CN1304380C Benzo[alpha]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II |
03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
03/13/2007 | US7189864 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
03/13/2007 | US7189724 For therapy of viral diseases |
03/13/2007 | US7189722 Aryl spirohydantoin CGRP receptor antagonists |
03/13/2007 | US7189719 Sodium channel blockers |
03/13/2007 | US7189483 Phenothiazine, phenoxazine, or phenazine derivatives; organophotoreceptor comprising electricoconductive substrate and photoconductive element; mechanical, electrostatic, and solubility properties; used with toners for quality images |
03/08/2007 | WO2007005774A9 Novel derivatives of amino acids for treatment of obesity and related disorders |
03/08/2007 | US20070055065 3-amidinophenylalanine derivatives such as N-(2-aminoethyl)-1-[(2S)-3-(3-carbamimidoylphenyl)-2-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]propanoyl]piperidine-4-carboxamide, used as inhibitors of matriptase, for the prophylaxis of tumors |
03/08/2007 | US20070054897 1,1-Dicyclohexyl-3-thiazol-2-yl-urea, 3-(5-Chloro-thiazol-2-yl)-1,1-dicyclohexyl-urea, for example; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
03/08/2007 | CA2618970A1 Lisofylline analogs and methods for use |
03/07/2007 | EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase |
03/07/2007 | EP1758865A1 Pyridine analogs as c5a antagonists |
03/07/2007 | EP1758861A1 Dpp-iv inhibitors |
03/07/2007 | CN1926094A Amide derivatives, process for production of the same, and method for application thereof as insecticide |
03/07/2007 | CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
03/06/2007 | US7186834 Substituted iminoazines |
03/06/2007 | US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
03/06/2007 | US7186735 Vasodilation; cardiovascular disorders; anticoagulants |
03/06/2007 | US7186725 Anti-inflammatory compositions and methods |
03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
03/06/2007 | US7186723 Tyrosine kinase inhibitors |
03/06/2007 | US7186721 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines |
03/06/2007 | US7186719 Antibacterial agents |
03/06/2007 | CA2200898C Process for the preparation of arylamides of heteroaromatic carboxylic acids |
03/01/2007 | WO2007024922A1 Immunosuppressant compounds and compositions |
03/01/2007 | WO2007024833A1 Anthranilamides for controlling invertebrate pests |
03/01/2007 | WO2007023882A1 Derivative having ppar agonistic activity |
03/01/2007 | WO2007023186A1 Pyrazine derivatives and use as pi3k inhibitors |
03/01/2007 | WO2007022638A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
03/01/2007 | US20070049602 Selective Apoptotic Induction in Cancer Cells Including Activation of Procaspase-3 |
03/01/2007 | CA2621164A1 Derivative having ppar agonistic activity |
03/01/2007 | CA2620414A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
03/01/2007 | CA2619101A1 Immunosuppressant compounds and compositions |
03/01/2007 | CA2618479A1 Pyrazine derivatives and use as pi3k inhibitors |
02/28/2007 | EP1757600A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
02/28/2007 | EP1757595A1 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof |
02/28/2007 | EP1756119A1 Collection of traceable compounds and uses thereof |
02/28/2007 | EP1756060A1 Therapeutic compounds: pyridine as scaffold |
02/28/2007 | EP1755605A2 Use of (4-alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease |
02/28/2007 | EP1687856B1 Electroluminescent devices comprising 2-(p-triphenyl)-3-phenyl-pyrazine derivatives |
02/28/2007 | CN1922160A Compounds |
02/28/2007 | CN1921893A Catalytic radiofluorination |
02/28/2007 | CN1302002C Hydroxylamine esters as polymerization initiators |
02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
02/22/2007 | WO2006105051A3 Synthesis of diketopiperazines |
02/22/2007 | US20070043217 Method for the distillative separation of mixtures containing ethyleneamines |
02/22/2007 | US20070043056 5-Substituted-2-arylpyrazines |
02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
02/21/2007 | EP1753713A2 Synthesis of tetracyclines and analogues thereof |
02/21/2007 | EP1753429A1 Modulators of muscarinic receptors |
02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
02/21/2007 | EP1458690B1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
02/21/2007 | CN1918135A Aminoquinoxaline compound, polyaminoquinoxaline compound, and use thereof |
02/21/2007 | CN1918133A Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases |
02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
02/21/2007 | CN1916009A Process for preparing amine platinum complexes |
02/21/2007 | CN1301254C Preparation of catifloxacin and purifying method |
02/21/2007 | CN1301251C Compound of alpha, beta and beta, gamma unsaturation carboxylate class of possessing weeding activity |
02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
02/20/2007 | US7179807 5-substituted-2-arylpyrazines |
02/20/2007 | US7179803 Method of modulating ion channel functional activity |
02/15/2007 | WO2007018640A1 New capped pyrazinoylguanidine sodium channel blockers |
02/15/2007 | US20070037980 under pressure at elevated temperature, by discharging the ethylenediamine at the top and the piperazine at the bottom of a distillation column |
02/15/2007 | US20070037858 Hexyl carboxanilides and their use for controlling undesirable micro-organisms |
02/15/2007 | US20070037821 Nitrosated glutamic acid compounds, compositions and methods of use |
02/15/2007 | US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
02/15/2007 | CA2820233A1 Perylenequinone derivatives and uses thereof |
02/15/2007 | CA2617269A1 New capped pyrazinoylguanidine sodium channel blockers |
02/14/2007 | EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
02/14/2007 | EP0999256B1 Compounds for organic el element and organic el element |
02/14/2007 | CN1913778A Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
02/14/2007 | CN1911914A Process for distillatively removing piperazine from an ethylenediamine-piperazine mixture |
02/13/2007 | US7176312 Kinase inhibitor scaffolds and methods for their preparation |
02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
02/13/2007 | CA2122236C Quinolines and their analogs |
02/08/2007 | WO2007014607A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
02/08/2007 | WO2006110477A3 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
02/08/2007 | US20070032509 New capped pyrazinoylguanidine sodium channel blockers |
02/08/2007 | US20070032499 Novel cysteine protease inhibitors and their therapeutic applications |
02/08/2007 | CA2616682A1 Squaric acid derivatives as protein kinase inhibitors |
02/07/2007 | EP1749823A1 Amine compound and organic electroluminescent element employing the same |
02/07/2007 | EP1749822A1 Novel cysteine protease inhibitors and their therapeutic applications |
02/07/2007 | EP1749818A2 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
02/07/2007 | EP1749032A1 Alkoxyamines containing a radically polymerizable group |
02/07/2007 | EP1748987A2 2-propene-1-ones as hsp 70 inducers |
02/07/2007 | EP1651622B1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
02/07/2007 | CN1910166A Heteroaryl-ureas and their use as glucokinase activators |
02/07/2007 | CN1907985A N,N-dimethylaminoacyl-2,3-difuryl-6-aminoquinoxaline, preparation method and application thereof |
02/07/2007 | CN1298718C Derivative of sinomenine with pyrazinc cyclc being connected to C cycle, synthetic method and application |
02/07/2007 | CN1298704C Isatine derivatives with neurotrophic activity |
02/06/2007 | US7173154 Transfection reagents |